Department of Clinical Sciences, Umeå University, Umeå, Sweden.
Department of Women's and Children's Health, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Transl Psychiatry. 2023 Apr 14;13(1):124. doi: 10.1038/s41398-023-02424-3.
Premenstrual dysphoric disorder (PMDD) is a debilitating disorder characterized by severe mood symptoms in the luteal phase of the menstrual cycle. PMDD symptoms are hypothesized to be linked to an altered sensitivity to normal luteal phase levels of allopregnanolone (ALLO), a GABA-modulating progesterone metabolite. Moreover, the endogenous 3β-epimer of ALLO, isoallopregnanolone (ISO), has been shown to alleviate PMDD symptoms through its selective and dose-dependent antagonism of the ALLO effect. There is preliminary evidence showing altered recruitment of brain regions during emotion processing in PMDD, but whether this is associated to serum levels of ALLO, ISO or their relative concentration is unknown. In the present study, subjects with PMDD and asymptomatic controls underwent functional magnetic resonance imaging (fMRI) in the mid-follicular and the late-luteal phase of the menstrual cycle. Brain responses to emotional stimuli were investigated and related to serum levels of ovarian steroids, the neurosteroids ALLO, ISO, and their ratio ISO/ALLO. Participants with PMDD exhibited greater activity in brain regions which are part of emotion-processing networks during the late-luteal phase of the menstrual cycle. Furthermore, activity in key regions of emotion processing networks - the parahippocampal gyrus and amygdala - was differentially associated to the ratio of ISO/ALLO levels in PMDD subjects and controls. Specifically, a positive relationship between ISO/ALLO levels and brain activity was found in PMDD subjects, while the opposite was observed in controls. In conclusion, individuals with PMDD show altered emotion-induced brain responses in the late-luteal phase of the menstrual cycle which may be related to an abnormal response to physiological levels of GABA-active neurosteroids.
经前期烦躁障碍(PMDD)是一种使人虚弱的疾病,其特征是在月经周期的黄体期出现严重的情绪症状。PMDD 症状被假设与对正常黄体期水平的别孕烯醇酮(ALLO)的敏感性改变有关,ALLO 是一种调节 GABA 的孕激素代谢物。此外,ALLO 的内源性 3β-差向异构体,异孕烯醇酮(ISO),已被证明通过其对 ALLO 效应的选择性和剂量依赖性拮抗作用来缓解 PMDD 症状。有初步证据表明,在 PMDD 中,情绪处理过程中大脑区域的募集发生改变,但这是否与 ALLO、ISO 或其相对浓度的血清水平有关尚不清楚。在本研究中,PMDD 患者和无症状对照者在月经周期的中卵泡期和黄体晚期进行了功能磁共振成像(fMRI)检查。研究了对情绪刺激的大脑反应,并将其与卵巢类固醇、神经甾体 ALLO、ISO 及其比值 ISO/ALLO 的血清水平相关联。在月经周期的黄体晚期,PMDD 患者的大脑区域对情绪刺激的反应更加活跃,这些区域是情绪处理网络的一部分。此外,情绪处理网络的关键区域——海马旁回和杏仁核——的活动与 PMDD 患者和对照组中 ISO/ALLO 水平的比值存在差异相关。具体而言,在 PMDD 患者中,ISO/ALLO 水平与大脑活动之间存在正相关关系,而在对照组中则观察到相反的情况。总之,PMDD 患者在月经周期的黄体晚期表现出改变的情绪诱导的大脑反应,这可能与对生理水平的 GABA 活性神经甾体的异常反应有关。